A Phase 4 interventional study of Stannous Fluoride Toothpaste (SnF) and sodium fluoride 5000 ppm in Elderly, Periodontal Disease and Gingivitis, sponsored by Colgate Palmolive. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-08.
Sponsored by Colgate Palmolive · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies testing Tin Fluorides in Gingivitis — 1 open to participants now, 3 under way, none of them phase 3. Tin Fluorides · Gingivitis.
Among the 23 studies testing Tin Fluorides in Gingivitis, this one is the 2nd largest by planned enrollment, is one of 2 that started in 2026, is one of 7 in phase 4, and was the 23rd registered.
633 studies on the registry are indexed under Gingivitis; 108 are open to participants now.
Browse Gingivitis studies →1 of the 23 studies testing Tin Fluorides in Gingivitis is open now.
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger; 11 take children under 18; 35 take healthy volunteers.
This study: 60 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 500 is above the median of 66 across 509 interventional studies indexed under Gingivitis.
Median enrollment 115 across the 23 interventional studies. Of the 20 that completed or were terminated, 7 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 23 have an industry lead sponsor. The 6 most frequent:
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
44 studies in Gingivitis by Colgate Palmolive: 8 open now, 9 under way, 5 of them phase 3. Of 35 finished, 8 (23%) have results posted.
Among the 44 studies in Gingivitis by Colgate Palmolive, this one has the largest planned enrollment, is one of 12 that started in 2026, is one of 12 in phase 4, and was the 41st registered.
Colgate Palmolive’s Gingivitis studies by the year they started, since 2007.
1 of the studies testing Tin Fluorides in Gingivitis that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07807397Colgate PalmoliveOral Hygiene Assistance Training Program | 2027-09 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies testing Tin Fluorides in Gingivitis, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Colgate Palmolive’s 44 in Gingivitis:
This tab as a report to print or save as PDF → With an account.
This is an oral health study with a nursing home staff training program and product intervention.
This study will be completed in partnership with the Missouri Department of Health and Senior Services, McCoy Samples Mattingly Dental Clinic, and Feno, inc. The study involves a nursing home staff training program, product intervention, and oral health outcomes.
633 studies on the registry are indexed under Gingivitis; 108 are open to participants now.
This study's planned enrollment of 500 is above the median of 66 across 509 interventional studies indexed under Gingivitis.
Browse Gingivitis studies →Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
Compared within Gingivitis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Periodontal Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects in this arm of the trial will use a manual or power toothbrush, OTC and/or Rx toothpaste, and OTC and/or Rx mouthwash.
Drug: Stannous Fluoride Toothpaste (SnF) · Drug: sodium fluoride 5000 ppm · Drug: cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash · Drug: sodium fluoride Mouthwash · Drug: Chlorhexidine 0,12%
Subjects in this arm of the trial will use a smart toothbrush, a cosmetic toothpaste, and an OTC and/or Rx mouthwash.
Drug: sodium fluoride Mouthwash · Drug: Chlorhexidine 0,12% · Device: connected toothbrush · Other: xylitol toothpaste
Cohort A will use a stannous fluoride toothpaste
Cohort A will have the option of using a sodium fluoride 5000 ppm toothpaste if prescribed by the dentist.
Cohort A will use an antiplaque/antigingivitis mouthwash
Cohort A and Cohort B may use the sodium fluoride OTC mouthwash
Cohort A and Cohort B may use a 0.12% chlorhexidine alcohol free mouthwash
Cohort B will use a u-shaped connected "smart" toothbrush
Cohort B will use a xylitol toothpaste
Incidence of pneumonia
Incidence of pneumonia acquired during the study
Time frame: 1 year
Diabetes status
Time frame: every 3 months for 1 year
HbA1c value
Time frame: Every 3 months for 1 year
Oral Health History
Significant history of oral health
Time frame: Baseline
Oral Health Status
This includes plaque, calculus, stain, visible inflammation, and oral hygiene status
Time frame: Monthly for one year
Level of adherence to oral hygiene regimen
This is a measure of how adherent the nursing home staff was in completing each instance of oral hygiene regimens for the subjects.
Time frame: Monthly for 1 year
Satisfaction with program
This will be captured via surveys for the subjects, facility staff, and facility leadership at different times throughout the study.
Time frame: 1 year
No study locations are listed for this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
Of 25 phase 4 interventional studies under Gingivitis, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 4. This study's planned 12 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tin Fluorides